A cancer patient has new hope for a cancer cure now. Let us look into details to beat cancer with the new drug Dostarlimab. ... Jun 09
With this collaboration GSK is uniquely positioned with access to antibodies that synergistically target all three known CD226 checkpoints - TIGIT, CD96 and PVRIG.... Jun 14
GSK gets FDA nod for Jemperli indicated for endometrial cancer... Apr 26
GSK plc announced updated data from GARNET cohort F evaluating dostarlimab in mismatch repair-deficient non-endometrial advanced solid cancers being presented today at the ... Jan 18
-Advertisements-